DJIA 17,131.97 100.83 0.59%
NASDAQ 4,552.76 33.86 0.75%
S&P 500 1,998.98 14.85 0.75%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

73.64 -0.14 (-0.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $73.64 -0.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.75
Previous Close $73.78
Daily Range $72.65 - $73.92
52-Week Range $49.63 - $82.68
Market Cap $93.0B
P/E Ratio 36.17
Dividend (Yield) $1.80 (3.8%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/15/14
Volume 2,391,207
Average Daily Volume 2,373,851
Current FY EPS $4.46

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

Update: AstraZeneca Announces Licensing Agreement

Drugs Stocks On The Rise With Help From 3 Stocks

Teva Pharmaceutical Is Poised To Grow

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

A Top Dividend Stock for Your Portfolio: Johnson & Johnson

This healthcare stock offers investors an attractive dividend yield, a strong balance sheet, and a long history of market-beating returns.

AstraZeneca Presents Unfavorable Benralizumab Study Data - Analyst Blog

See More AZN News...

AZN's Top Competitors

AZN $73.64 (-0.19%)
Current stock: AZN
JNJ $105.88 (1.11%)
Current stock: JNJ
NVS $94.38 (0.21%)
Current stock: NVS
RHHBY $37.48 (1.41%)
Current stock: RHHBY